Who may be considered
- Localized, image-visible or accurately mapped clinically significant cancer
- Disease distribution suitable for an adequate treatment margin
- Men prioritizing tissue preservation who accept close follow-up
Targeted prostate cancer treatment
Image-guided freezing of the cancer-bearing portion of the prostate, with the intent of controlling clinically significant disease while reducing injury to uninvolved tissue.
Clinical experience since 2007
Dr. Al Barqawi is one of the most experienced prostate cryotherapy surgeons in the United States. His prospective research has evaluated cancer control, urinary outcomes, sexual function and treatment safety.
At a glance
Thin cryoprobes are placed through the perineum under ultrasound guidance. Repeated freeze–thaw cycles create an ice ball around the planned treatment zone and destroy tissue within it. Temperature monitoring and warming of the urethra help protect nearby structures.
Focal treatment does not remove or treat the entire gland. Accurate localization and confidence that clinically significant disease is limited to a treatable region are therefore essential.
From Dr. Barqawi’s YouTube channel
This brief procedure clip is published by Dr. Barqawi. It demonstrates cryoprobe placement and is provided for education; an individual treatment plan may be focal or whole-gland.
Evidence & follow-up
Focal cryotherapy has encouraging medium-term cancer-control and functional results in selected men, but randomized comparative and long-term data are less mature than for prostatectomy or radiation. Follow-up generally includes PSA testing, MRI and a planned repeat biopsy.
Candidacy depends on pathology, MRI, biopsy mapping, tumor position, prostate anatomy and personal priorities.
Contact the clinicGeneral education only. Treatment suitability, risks and outcomes vary by patient.